NCT03846570 - Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

July 5, 2022

Study Completion Date

July 5, 2022

Conditions

Bronchiectasis

Interventions

DRUG

Formoterol-beclomethasone

formoterol (fumarate dihydrate) 12 microg - beclomethasone (dipropionate) 200 microg administered BID, per inhalation using '100/6' Metered Dose Inhaler

DRUG

Placebo

Matching placebo (identically package) administered BID

Trial Locations (3)

3015GD

Tjeerd van der Veer, Rotterdam

Unknown

Franciscus Gasthuis & Vlietland, Rotterdam

HagaZiekenhuis, The Hague